1. Home
  2. ELTK vs LPCN Comparison

ELTK vs LPCN Comparison

Compare ELTK & LPCN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Eltek Ltd.

ELTK

Eltek Ltd.

HOLD

Current Price

$9.20

Market Cap

57.3M

Sector

Technology

ML Signal

HOLD

Logo Lipocine Inc.

LPCN

Lipocine Inc.

HOLD

Current Price

$10.87

Market Cap

61.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ELTK
LPCN
Founded
1970
1997
Country
Israel
United States
Employees
N/A
N/A
Industry
Electrical Products
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
57.3M
61.8M
IPO Year
1997
N/A

Fundamental Metrics

Financial Performance
Metric
ELTK
LPCN
Price
$9.20
$10.87
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$7.00
AVG Volume (30 Days)
5.7K
246.3K
Earning Date
03-10-2026
11-06-2025
Dividend Yield
2.02%
N/A
EPS Growth
N/A
N/A
EPS
0.17
N/A
Revenue
$49,310,000.00
$4,322,693.00
Revenue This Year
$18.60
N/A
Revenue Next Year
$9.04
N/A
P/E Ratio
$54.51
N/A
Revenue Growth
2.54
N/A
52 Week Low
$7.65
$2.52
52 Week High
$12.19
$12.37

Technical Indicators

Market Signals
Indicator
ELTK
LPCN
Relative Strength Index (RSI) 54.03 80.94
Support Level $8.64 $10.56
Resistance Level $9.41 $12.37
Average True Range (ATR) 0.24 1.06
MACD 0.11 0.32
Stochastic Oscillator 64.06 74.50

Price Performance

Historical Comparison
ELTK
LPCN

About ELTK Eltek Ltd.

Eltek Ltd is engaged in the technology business sector that manufactures and supplies technologically new custom-made circuitry solutions. It manufactures, markets, and sells custom-made printed circuit boards (PCBs), including high-density interconnect, flex-rigid and multi-layered boards. The Company markets its products mainly to the medical technology, defense and aerospace, industrial, telecom, and networking equipment industries. Its geographic areas are Israel, North America, the Netherlands, India, and Others. It generates the majority of its revenue from Israel.

About LPCN Lipocine Inc.

Lipocine Inc is a clinical-stage biopharmaceutical company, that is engaged in research and development for the delivery of drugs using its proprietary delivery technology. Its principal operation is to provide oral delivery solutions for existing drugs. Lipocine develops its drug candidates or it develops drug candidates on behalf of or in collaboration with corporate partners. The company's product TLANDO is an oral testosterone replacement therapy ("TRT"). It also has other products in the pipeline such as LPCN 1144, TLANDO, TLANDO XR, LPCN 1148, LPCN 1107, LPCN 1154, and LIP'RAL7 Technology. The Company has a single reportable segment, research, and development for the delivery of drugs using its proprietary delivery technology.

Share on Social Networks: